Rocky Mountain High Brands Announces Launch of Its HEMPd

New Post Public Reply Private Reply Replies (1) Message Board
jettyjams
563
Rocky Mountain High Brands Announces Launch of Its HEMPd CBD-Infused Flavored Waters

DALLAS, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTCQB: RMHB), a fully reporting lifestyle brand management company specializing in high-quality health and wellness products, announced today that it has launched its HEMPd Infusion Flavored Waters on the Company's www.HEMPd.com website.

Michael Welch, President and Chief Executive Officer of Rocky Mountain High Brands, Inc., stated, "We are excited to enter the CBD-infused beverage field with our four flavors of HEMPd Infusion Flavored Waters - Raspberry Lemonade, Peach Mango, Dragon Fruit, and Pineapple Coconut. Our lightly carbonated beverages are delivered in crisp looking, colorful 12 ounce cans. Each beverage contains 5 MG of full plant CBD. Our beverages are intended as the perfect grab and go option or to drink with a meal for those looking for a healthier alternative. For convenience, these beverages are offered as a twelve pack case by flavor as well as a variety pack that includes three of our 12 ounce cans per flavor."

Welch continued, "The CBD market is projected to be $22 billion by 2022*. Bloomberg reported on September 17, 2018 that Coca Cola was interested in drinks infused with CBD. We are taking advantage of this market opportunity using the expertise developed infusing CBD into beverages through our agreement with CBD Alimentos. Launching our HEMPd Infusion Flavored Waters is a huge step for the Company as we get back to our legacy beverage roots in the sky-rocketing CBD space."

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Hims & Hers Health Faces Revenue Challenges and Legal Issues

Updated Category News Views 246

Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...

Continue Reading
Entrée Resources Reports Solid Results for Q3 2025

Updated Category News Views 166

Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...

Continue Reading
Bucket List Wine Dinners Beckon to Los Angeles

Updated Category News Views 10

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Continue Reading
BioLife Solutions Enhances Growth Potential with $73 Million Sale

Updated Category News Views 68

BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...

Continue Reading
Advancements in Universal Vaccine Development by Dx&Vx

Updated Category News Views 154

Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....

Continue Reading